Commentary: Biotechnology lets scientists engineer natural ingredients into products, often more sustainably than if they were farmed. Here's what to know. Deenie is a CNET Perspectives contributor ...
The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and ...
Nanoscience can offer solutions, not only problems, to environmental challenges, addressing pollution and enhancing ...
A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...
Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...
For more than a decade, Boston has been the undisputed capital of the world’s life sciences industry. No other city really comes close. There is more lab space in Boston and Cambridge than anywhere in ...
The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...
Nobel Prize winners, from left: Mary Brunkow, senior program manager at the Institute for Systems Biology, Fred Ramsdell, co-founder and chair of Sonoma Biotherapeutic’s scientific advisory board; and ...
Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...
New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated with Alzheimer’s disease. Amongst the risks are inflammation-related ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The German biotech Tubulis, which is designing a series of ...
Biotech is "at the cusp of a golden age" in the U.S., and Illinois will capitalize on it by taking advantage of the changes on the horizon, like AI and quantum science, said John Crowley, president ...